News on Medial

Related News

NephroPlus posts Rs 566 Cr revenue and Rs 35 Cr profit in FY24

EntrackrEntrackr · 9m ago
NephroPlus posts Rs 566 Cr revenue and Rs 35 Cr profit in FY24
Medial

NephroPlus posts Rs 566 Cr revenue and Rs 35 Cr profit in FY24 Dialysis service provider NephroPlus reported a 29% year-on-year increase in operating revenue for the fiscal year ending March 2024. Significantly, the Hyderabad-based company turned profitable during the period, marking a notable recovery from a Rs 12 crore loss in FY23. NephroPlus’ operating revenue grew to Rs 566 crore in FY24 from Rs 438 crore in FY23, according to its consolidated financial statement sourced from the Registrar of Companies (RoC). NephroPlus runs over 275 dialysis centers in more than 170 cities in India and treats nearly 20,000 patients on a monthly basis. Revenue from these services accounted for 95% of the company’s income in FY24. On the expense side, the largest component of expenditure remained the cost of materials, which rose 19% to Rs 169 crore, accounting for over 31% of the total spend. Employee benefit expenses dropped slightly to Rs 91 crore from Rs 97 crore in FY23, while healthcare professional fees surged by 90% to Rs 59 crore. Hospital fees also increased to Rs 56 crore from Rs 48 crore, and other operational expenses climbed to Rs 166 crore. Overall, NephroPlus reported total costs rose 19.7% to Rs 541 crore in FY24. The strategic focus on cost discipline and improved margins helped NephroPlus post a net profit of Rs 35 crore in FY24, as compared to a net loss of Rs 12 crore a year earlier. Its ROCE and EBITDA margin improved to 9.40% and 18.96% respectively. On a unit basis, NephroPlus spent Rs 0.96 to earn a rupee of revenue in FY24. As of March 2024, the company reported current assets worth Rs 390 crore in FY24, out of which Rs 61 crore were in cash and bank balances. According to startup data intelligence platform TheKredible, NephroPlus has raised approximately $212 million in funding to date, having IFC and Besemer Venture Partners as its lead investors. The company’s co-founder and CEO Vikram Vuppala owns 11.6% of the company. Recently, NephroPlus acquired seven new dialysis clinics in the Philippines. The firm is also planning to start its clinics in Saudi Arabia later this year.

Paytm posts Rs 2,194 Cr revenue and Rs 225 Cr profit in Q3 FY26

EntrackrEntrackr · 2d ago
Paytm posts Rs 2,194 Cr revenue and Rs 225 Cr profit in Q3 FY26
Medial

Fintech firm Paytm announced its financial results for the third quarter of the ongoing fiscal year (Q3 FY26) on Thursday. The Noida-based company reported a revenue of Rs 2,194 crore and a net profit of Rs 225 crore for the period. According to Paytm’s unaudited quarterly report filed with the National Stock Exchange, its revenue from operations increased by 20% year-on-year from Rs 1,828 crore in Q3 FY25. The company also added Rs 212 crore from other non-operating sources, bringing its overall revenue to Rs 2,406 crore in Q3 FY26. For the nine-months period, Paytm’s revenue rose 24% to Rs 6,173 crore from Rs 4,989 crore, a year earlier. For the Noida-based firm, its employee benefits remained the largest cost center, accounting for 33% of the overall cost, which decreased by 5% to Rs 721 crore in Q3 FY26. Its payment processing charges increased by 17.5% to Rs 671 crore, and marketing expenses increased by 3.5% to Rs 146 crore in Q3 FY26. Software, communication, legal, cashback, and other overheads took the total expenditure to Rs 2,175 crore in Q3 FY26, as compared to Rs 2,220 crore in Q3 FY25. Paytm recorded a net profit of Rs 225 crore in Q3 FY26, in contrast to a loss of Rs 208 crore in Q3 FY25. On a sequential basis, the company’s profit increased by more than 10X from Rs 21 crore in Q2 FY26. Last quarter was eventful for the company as it received authorisation from the RBI to operate as a payment aggregator for physical or offline payments and cross border transactions. The company also granted ESOPs worth Rs 16.6 crore and Rs 60 crore under its ESOP Scheme 2019. Paytm also witnessed a significant shareholder shift as Elevation Capital (formerly SAIF Partners) offloaded a 1.86% stake in the fintech major through a bulk deal worth Rs 1,556 crore. Five days later, BNP Paribas sold 1 crore shares of Paytm worth Rs 1,331 crore. Alongside this, Integrated Core Strategies sold 32.55 lakh shares worth Rs 410 crore. As of January 29, Paytm’s share price stood at Rs 1,172 with the total market capitalization standing at Rs 74,963 crore ($8 billion).

Download the medial app to read full posts, comements and news.